Publicaciones en las que colabora con Pablo Juan Álvarez Aránega (18)

2018

  1. Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review

    Nutrition and Cancer, Vol. 70, Núm. 4, pp. 569-578

2017

  1. Gastrointestinal stromal tumours: An actualized overview

    European Journal of Anatomy, Vol. 21, Núm. 2, pp. 97-112

2015

  1. Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells

    PLoS ONE, Vol. 10, Núm. 7

  2. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer

    AAPS Journal, Vol. 17, Núm. 4, pp. 918-929

2014

  1. Qualitative and quantitative analyses of anatomists' research: Evaluation of multidisciplinarity and trends in scientific production

    Scientometrics, Vol. 98, Núm. 1, pp. 447-456

  2. Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers

    Digestive Diseases and Sciences, Vol. 59, Núm. 11, pp. 2714-2720

2013

  1. Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance

    Cancer Chemotherapy and Pharmacology, Vol. 71, Núm. 2, pp. 537-541

  2. Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing

    BioMed Research International, Vol. 2013

2012

  1. 5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

    International Journal of Nanomedicine, Vol. 7, pp. 95-107

  2. Development and morphogenesis of human wrist joint during embryonic and early fetal period

    Journal of Anatomy, Vol. 220, Núm. 6, pp. 580-590

  3. Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells

    Biomedicine and Pharmacotherapy, Vol. 66, Núm. 7, pp. 563-567

  4. How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment

    Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888

  5. Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure

    International Journal of Molecular Sciences, Vol. 13, Núm. 12, pp. 16624-16635

  6. New gene therapy strategies for cancer treatment: A review of recent patents

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Núm. 3, pp. 297-312

  7. The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis

    European Journal of Medicinal Chemistry, Vol. 50, pp. 376-382

2011

  1. gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathway

    International Journal of Molecular Sciences, Vol. 12, Núm. 11, pp. 7445-7458

2010

  1. Differentiation of intestinal epithelial cells mediated by cell confluence and/or exogenous nucleoside supplementation

    Cells Tissues Organs, Vol. 191, Núm. 6, pp. 478-488

  2. E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents

    International Journal of Oncology, Vol. 37, Núm. 6, pp. 1503-1514